Theses reviewed in this issue include Characterization and Modeling of Metabolic Stress Responses in Cellular Aging; Engineering Immunity: Enhancing T Cell Vaccines and Combination Immunotherapies for the Treatment of Cancer; Extracellular Inflammatory Signaling from Dysfunctional Telomeres; High-Throughput Microfluidic Labyrinth for the Label-Free Isolation of circulating tumor cells for Single-Cell Gene Expression Profiling; Oxygen Nanobubbles for Ultrasound-guided Targeting of Cancer Hypoxia; and The Eye as a Window to the Alzheimer's Disease Brain.
Get full access to this article
View all access options for this article.
References
1.
ZealleyB, de GreyADNJ. Commentary on some recent theses relevant to combating aging: February 2017. Rejuvenation Res, 2017; 20:67–74.
2.
ZealleyB, de GreyADNJ. Commentary on some recent theses relevant to combating aging: April 2017. Rejuvenation Res, 2017; 20:151–154.
3.
ZealleyB, de GreyADNJ. Commentary on some recent theses relevant to combating aging: June 2017. Rejuvenation Res, 2017; 20:248–253.
4.
ZealleyB, de GreyADNJ. Commentary on some recent theses relevant to combating aging: August 2017. Rejuvenation Res, 2017; 20:350–356.
5.
ZealleyB, de GreyADNJ. Commentary on some recent theses relevant to combating aging: December 2017. Rejuvenation Res, 2017; 20:530–535.
6.
ZealleyB, de GreyADNJ. Commentary on some recent theses relevant to combating aging: February 2018. Rejuvenation Res, 2018; 21:70–76.
7.
ZealleyB, de GreyADNJ. Commentary on some recent theses relevant to combating aging: April 2018. Rejuvenation Res, 2018; 21:173–177.
8.
ZealleyB, de GreyADNJ. Commentary on some recent theses relevant to combating aging: August 2018. Rejuvenation Res, 2018; 21:374–379.
9.
ZealleyB, de GreyADNJ. Commentary on some recent theses relevant to combating aging: October 2018. Rejuvenation Res, 2018; 21:482–487.
10.
ZealleyB, de GreyADNJ. Commentary on some recent theses relevant to combating aging: December 2018. Rejuvenation Res, 2018; 21:580–586.
11.
GomesAP, PriceNL, LingAJ, et al.Declining NAD(+) induces a pseudohypoxic state disrupting nuclear-mitochondrial communication during aging. Cell, 2013; 155:1624–1638.
12.
MendelsohnAR, LarrickJW. The NAD+/PARP1/SIRT1 axis in aging. Rejuvenation Res, 2017; 20:244–247.
13.
PoljsakB, MilisavI. Restoring NAD(+) levels with NAD(+) intermediates, the second law of thermodynamics, and aging delay. Rejuvenation Res, 2018; 21:506–509.
14.
VastoS, AccardiG, AielloA, et al.Dietary supplements as surrogate of mediterranean diet in healthy smoking subjects. Rejuvenation Res, 2018; 21:37–43.
15.
TarragóMG, ChiniCCS, KanamoriKS, et al.A potent and specific CD38 inhibitor ameliorates age-related metabolic dysfunction by reversing tissue NAD+ decline. Cell Metab, 2018; 27:1081–1095.
16.
YamagishiSI, MatsuiT. Role of ligands of receptor for advanced glycation end products (RAGE) in peripheral artery disease. Rejuvenation Res, 2018; 21:456–463.
17.
MoynihanKD, HoldenRL, MehtaNK, et al.Enhancement of peptide vaccine immunogenicity by increasing lymphatic drainage and boosting serum stability. Cancer Immunol Res, 2018; 6:1025–1038.
18.
TzengA, KaukeMJ, ZhuEF, et al.Temporally programmed CD8α+ DC activation enhances combination cancer immunotherapy. Cell Rep, 2016; 17:2503–2511.
19.
MendelsohnAR, LarrickJW. Telomerase may paradoxically accelerate aging of the DNA methylome. Rejuvenation Res, 2018; 21:168–172.
20.
PiccaA, LezzaAMS, LeeuwenburghC, et al.Circulating mitochondrial DNA at the crossroads of mitochondrial dysfunction and inflammation during aging and muscle wasting disorders. Rejuvenation Res, 2018; 21:350–359.
21.
DidiotMC, HallLM, ColesAH, et al.Exosome-mediated delivery of hydrophobically modified siRNA for huntingtin mRNA silencing. Mol Ther, 2016; 24:1836–1847.
22.
ChabnerBA. Does chemotherapy induce metastases?. Oncologist, 2018; 23:273–274.
23.
MendelsohnAR, LarrickJW. Cellular senescence as the key intermediate in tau-mediated neurodegeneration. Rejuvenation Res, 2018; 21:572–579.
